Lynne S. Peterson, M.D.

Open

• A Real-world Comparative Effectiveness Trial of Treatment Strategies in Patients with Rheumatoid Arthritis: The RA-PRO (Patient Reported Outcomes) Pragmatic Trial (RA-PROPR) (RA-PROPR) Rochester, MN

  The overall objective of this study is to examine if the strategy starting of the addition of a tsDMARD, oral targeted molecule medications will lead to greater improvement in HAQ compared with the alternate approach of the addition of a non-TNF-biologic.